SHR-A1904 not checked

Hengrui

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
6 active
7 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Single Arm :It is a dose-escalation and dose-expansion study of SHR-A1904 in subjects with advanced solid tumors”In the company’s words, NCT05277168 on ClinicalTrials.gov
Tested for
Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Gastric Cancer, Metastatic Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Biliary Tract Cancer, Advanced Solid Tumors and 1 more
Main trialPhase 3
“The study evaluated the overall survival (OS) of SHR-A1904 versus investigator-selected treatment in second-line CLDN18.2-positive advanced GC/GEJC patients”In the company’s words, NCT06649292 on ClinicalTrials.gov

Other drugs for Gastric Cancer

All 208 drugs for Gastric Cancer

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials7

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 20 Sep 2027 SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 2Recruiting Aug 2026 A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
Phase 2Recruiting Dec 2027 Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
Phase 2Recruiting Dec 2030 A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer
Phase 1/2Recruiting May 2026 A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Phase 1Active, not recruiting 1 Dec 2025 A Study of SHR-A1904 in Patients With Advanced Solid Cancer
Phase 1Unknown 30 Jun 2023 A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow SHR-A1904

Following is part of Solo: you see every change to SHR-A1904 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in